You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: RE48923


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent RE48923 protect, and when does it expire?

Patent RE48923 protects MAVYRET and is included in two NDAs.

Protection for MAVYRET has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has ten patent family members in seven countries.

Summary for Patent: RE48923
Title:Crystal forms
Abstract: The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern as shown in one of FIGS. 1-10.
Inventor(s): Califano; Jean-Christophe (Whitefish Bay, WI), Fickes; Michael G. (Lake Bluff, IL), Nordstroem; Lars Fredrik (Evanston, IL)
Assignee: AbbVie Inc. (North Chicago, IL)
Application Number:15/830,544
Patent Claim Types:
see list of patent claims
Composition; Compound; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When navigating the complex landscape of U.S. patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the key aspects of patent claims, the importance of claim scope, and the broader patent landscape, using the context of U.S. Patent RE48923 as a reference point, although specific details of this patent are not provided here.

The Importance of Patent Claims

Patent claims are the heart of a patent application, defining the scope of protection for an invention. They must be clear, concise, and supported by the specification to ensure that the invention is adequately described and distinguishable from prior art[5].

Types of Claims

  • Independent Claims: These claims stand alone and do not depend on other claims. They define the broadest scope of the invention.
  • Dependent Claims: These claims rely on independent claims and narrow down the scope by adding additional limitations.
  • Method Claims: Describe a process or method.
  • Apparatus Claims: Describe a device or system.
  • Composition Claims: Describe a new material or compound[5].

Measuring Patent Scope

Patent scope is a critical factor in determining the breadth of protection a patent offers. Two simple metrics often used to measure patent scope are independent claim length and independent claim count[4].

Independent Claim Length

Longer independent claims typically indicate a narrower scope, as they include more specific limitations. Shorter claims, while broader, are more susceptible to invalidation due to their lack of specificity[4].

Independent Claim Count

A higher number of independent claims can indicate a broader scope, but it also increases the complexity and potential for overlap with prior art. Narrower claims, reflected by fewer independent claims, are often associated with a higher probability of grant and a shorter examination process[4].

Drafting Effective Patent Claims

Drafting patent claims is an art that requires balancing breadth and specificity.

Avoiding Overly Broad Claims

While broader claims may seem appealing, they are more difficult to get granted and easier to invalidate. Overly broad claims can fall under the abstract idea exception or fail to meet the written description requirement[5].

The Abstract Idea Exception

The Supreme Court's decision in Alice v. CLS Bank established a framework for determining whether a claimed invention is directed to an abstract idea. Claims that merely invoke generic processes and machinery without improving the relevant technology are likely to be deemed patent ineligible[5].

Anchoring Claims to the Specification

Claims must be anchored to the embodiments described in the specification. This ensures that the claims are supported and do not exceed the scope of the invention described[5].

The Patent Landscape and Recent Developments

Patent Fee Adjustments

The U.S. Patent and Trademark Office (USPTO) periodically adjusts patent fees to ensure financial sustainability and improve the predictability and reliability of patent intellectual property protection. These adjustments, authorized by the Leahy-Smith America Invents Act, include setting or adjusting fees to recover the aggregate estimated costs of patent processing and related activities[1].

Economic Impact and Regulatory Analysis

Proposed fee adjustments undergo a Regulatory Impact Analysis (RIA) to assess their qualitative and quantitative costs and benefits. This analysis ensures that the fee schedule aligns with key policy factors and supports the core mission and strategic priorities of the USPTO[1].

Patent Claims Research Dataset

The USPTO provides extensive datasets on patent claims, which include detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. These datasets help in analyzing patent scope and trends in the examination process[3].

Case Law and Judicial Interpretations

Berkheimer v. HP Inc.

In Berkheimer v. HP Inc., the Federal Circuit Court of Appeals addressed the validity of patent claims under 35 U.S.C. ยง 101. The court emphasized that claims must be more than just abstract ideas and must improve the relevant technology to be patent eligible. This decision highlights the importance of ensuring that claims are specific and transformative[2].

Best Practices for Patent Applicants

Understanding Prior Art

Prior art is crucial in determining the novelty and non-obviousness of an invention. In technical fields with extensive prior art, broader claims are more challenging to get allowed, and the risk of invalidation increases[5].

Budget and Technical Field Considerations

The claim scope should be tailored to the client's budget and the specific technical field. Broader claims in crowded fields can be costly and risky, while narrower claims may offer more targeted protection[5].

Key Takeaways

  • Clear and Specific Claims: Ensure that patent claims are clear, concise, and supported by the specification.
  • Balanced Scope: Avoid overly broad claims that may be easier to invalidate.
  • Anchoring to Specification: Claims must be anchored to the embodiments described in the specification.
  • Economic and Regulatory Considerations: Understand the economic and regulatory landscape, including fee adjustments and their impact.
  • Prior Art and Technical Field: Consider prior art and the technical field when drafting claims.

FAQs

What is the importance of independent claim length in patent scope?

Independent claim length is a metric used to measure patent scope. Longer independent claims typically indicate a narrower scope, which can be beneficial in avoiding invalidation.

How do patent fee adjustments impact patent applicants?

Patent fee adjustments, as proposed by the USPTO, can affect the financial burden on patent applicants. These adjustments aim to ensure financial sustainability and improve the reliability of patent protection.

What is the abstract idea exception in patent law?

The abstract idea exception, established by the Alice v. CLS Bank decision, holds that claims directed to abstract ideas, laws of nature, or natural phenomena are not patent eligible unless they improve the relevant technology.

Why is it important to anchor claims to the specification?

Anchoring claims to the specification ensures that the claims are supported and do not exceed the scope of the invention described, reducing the risk of invalidation.

How do datasets like the Patent Claims Research Dataset help in patent analysis?

These datasets provide detailed information on patent claims, helping in the analysis of patent scope trends and the examination process, which can inform better patent drafting and strategy.

Sources

  1. Federal Register/Vol. 89, No. 65/Wednesday, April 3, 2024 - GovInfo
  2. Berkheimer v. HP Inc. - Court of Appeals for the Federal Circuit
  3. Patent Claims Research Dataset - USPTO
  4. Patent Claims and Patent Scope - SSRN
  5. The Importance of Getting the Claim Scope Right in a US Patent Application - Rimon Law

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE48923

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie MAVYRET glecaprevir; pibrentasvir PELLETS;ORAL 215110-001 Jun 10, 2021 RX Yes Yes RE48923*PED ⤷  Subscribe Y ⤷  Subscribe
Abbvie MAVYRET glecaprevir; pibrentasvir TABLET;ORAL 209394-001 Aug 3, 2017 RX Yes Yes RE48923*PED ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent RE48923

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015255784 ⤷  Subscribe
Australia 2020203494 ⤷  Subscribe
Canada 2945205 ⤷  Subscribe
China 106458989 ⤷  Subscribe
European Patent Office 3140284 ⤷  Subscribe
Japan 2017515897 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.